Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled Apr. 5, 2023

Molnlycke Health Care US, LLC v. Greenwood Marketing, LLC

Judge
Cathy Seibel
Docket
7:22-cv-03719
Court
U.S. District Court · Southern District of New York
Pages
3
DiscoveryCivil Procedure
In one sentence

Molnlycke v. Greenwood: Judge Seibel ordered a conference and a response to a discovery letter without deciding whether samples must be produced.

Who this affects

The order directly affected the plaintiffs, Molnlycke Health Care US, LLC and Brock USA, LLC, by requiring them to respond to Greenwood’s letter. It also set a conference concerning Greenwood Marketing, LLC’s anticipated motion to compel production of product samples.

What happened

In Molnlycke Health Care US, LLC v. Greenwood Marketing, LLC, Greenwood asked the court to require production of samples of products that allegedly practice an asserted patent. Greenwood argued the samples could help it challenge Molnlycke’s potential claim for lost-profit damages.

Molnlycke had objected that the samples were irrelevant, beyond the patent claims at issue, or outside its control, and said documents would provide the necessary information. The parties met and discussed the dispute, but Molnlycke maintained its objections and refused to produce the samples.

Judge Cathy Seibel ordered a conference for May 1, 2023, to discuss the issues raised in Greenwood’s letter and directed the plaintiffs to respond by April 12. The court did not decide whether the samples must be produced.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Molnlycke Health Care US, LLC v. Greenwood Marketing, LLC · No. 7:22-cv-03719
Judge
Cathy Seibel
Date
Apr. 5, 2023

Background

The opinion text consists primarily of Greenwood Marketing, LLC, doing business as Restorative Medical, counsel’s letter requesting a pre-motion conference. Greenwood sought permission to pursue a motion compelling production of samples of Molnlycke Health Care US, LLC’s patient-positioning products and licensed third-party products that allegedly practice United States Patent No. 9,120,666.

Greenwood had served a document request seeking two samples of each plaintiff’s product, or licensed third-party product, allegedly practicing any claim of the asserted patents. Molnlycke objected that the request was irrelevant, was not limited to the asserted claims, and sought products outside its control. Molnlycke stated that it would not search for or produce responsive samples.

Parties’ Positions

Greenwood argued that the products were relevant to its defense against Molnlycke’s claim for damages. In particular, Greenwood stated that Molnlycke might rely on product sales to show demand for the patented product and support a claim for lost profits. Greenwood sought to inspect the products to determine whether they actually practice the patent. It also argued that licensed third-party products should be treated as within Molnlycke’s control if the applicable license agreements gave Molnlycke the right to obtain samples.

Molnlycke maintained that samples were irrelevant and that information about the products could be determined from documents produced in response to another request. The opinion text states that the parties met and conferred several times but did not resolve the dispute.

Court’s Action

Judge Cathy Seibel ordered that the court would hold a conference on May 1, 2023, at 11 a.m. in Courtroom 421 to discuss the issues raised in Greenwood’s letter. The court also directed the plaintiffs to respond to the letter by April 12, 2023.

The text does not state that the court granted or denied a motion to compel, and it does not decide whether Molnlycke must produce the requested samples. The court’s action was limited to scheduling the conference and requiring a response.

The authoritative version

Read the full 3-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.